The compound or its pharmaceutically acceptable salt of Formulas I, and method and production using them are provided. The compound is that public formula (I) IRAK-4 inhibitor can be used for treating inflammatory disease, autoimmunity disease, cancer, cardiovascular disease, disease Central nervous system, the skin of disease, ophthalmic disease and condition, osteopathy.
